Cancers, Vol. 10, Pages 474: The Emerging Role of TYRO3 as a Therapeutic Target in Cancer

Cancers, Vol. 10, Pages 474: The Emerging Role of TYRO3 as a Therapeutic Target in Cancer

Cancers doi: 10.3390/cancers10120474

Authors: Sherri K. Smart Eleana Vasileiadi Xiaodong Wang Deborah DeRyckere Douglas K. Graham

The TAM family (TYRO3, AXL, MERTK) tyrosine kinases play roles in diverse biological processes including immune regulation, clearance of apoptotic cells, platelet aggregation, and cell proliferation, survival, and migration. While AXL and MERTK have been extensively studied, less is known about TYRO3. Recent studies revealed roles for TYRO3 in cancer and suggest TYRO3 as a therapeutic target in this context. TYRO3 is overexpressed in many types of cancer and functions to promote tumor cell survival and/or proliferation, metastasis, and resistance to chemotherapy. In addition, higher levels of TYRO3 expression have been associated with decreased overall survival in patients with colorectal, hepatocellular, and breast cancers. Here we review the physiological roles for TYRO3 and its expression and functions in cancer cells and the tumor microenvironment, with emphasis on the signaling pathways that are regulated downstream of TYRO3 and emerging roles for TYRO3 in the immune system. Translational agents that target TYRO3 are also described.

https://ift.tt/2AAfqDx